Royalty Pharma Plc (RPRX) — Free Cash Flow Generation Index
Royalty Pharma Plc (RPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $760.54 Million represents 1% of operating cash flow ($760.54 Million). Explore RPRX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Royalty Pharma Plc Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Royalty Pharma Plc across 11 annual periods. For the full cash flow conversion analysis, see Royalty Pharma Plc cash flow conversion.
Annual Free Cash Flow Generation for Royalty Pharma Plc (2002–2025)
Year-by-year Free Cash Flow Generation Index for Royalty Pharma Plc. Check Royalty Pharma Plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $2.49 Billion | $2.49 Billion | $0.00 | ▲ +0.0% |
| 2024 | 1.00x | $2.77 Billion | $2.77 Billion | $0.00 | ▲ +0.0% |
| 2023 | 1.00x | $2.99 Billion | $2.99 Billion | $2.12 Billion | ▼ -48.8% |
| 2022 | 1.95x | $4.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +95.2% |
| 2021 | 1.00x | $2.02 Billion | $2.02 Billion | $523.00K | ▼ -51.9% |
| 2020 | 2.08x | $4.23 Billion | $2.03 Billion | $2.20 Billion | ▲ +108.0% |
| 2019 | 1.00x | $1.67 Billion | $1.67 Billion | $1.72 Billion | ▲ +0.0% |
| 2018 | 1.00x | $1.62 Billion | $1.62 Billion | $269.59 Million | ▲ +0.0% |
| 2017 | 1.00x | $1.42 Billion | $1.42 Billion | $2.29 Billion | ▲ +0.0% |
| 2003 | 1.00x | $11.15 Million | $11.15 Million | $0.00 | ▼ -0.6% |
| 2002 | 1.01x | $8.49 Million | $8.45 Million | $49.00K | — |